Latest Stock Split Details
Key information about Middle East Pharmaceutical Industries Company's most recent stock split
Split Date: 2026-05-12
Split Ratio: 7:4
Price Before Split: $101.59
Price After Split: $58.05
Developer API
Get 4016.SR split history as JSON
Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.
GETapi.roic.ai/v2/stock-splits/4016.SR
Impact of the Stock Split
Understanding what this means for shareholders
- The total value of your investment remains the same
- You now own 1.75 times more shares (a 7:4 ratio)
- The price per share is reduced proportionally
Historical Stock Splits
A comprehensive history of Middle East Pharmaceutical Industries Company's stock splits
| Date | Ratio | Is Reverse Split | Price Before Split | Price After Split |
|---|---|---|---|---|
| 2026-05-12 | 7:4 | No | $101.59 | $58.05 |
About Middle East Pharmaceutical Industries Company
Company overview and industry information
Middle East Pharmaceutical Industries Company (4016.SR) operates in the Medical - Pharmaceuticals industry. The recent 7-for-4 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.
Medical - Pharmaceuticals
Go to Middle East Pharmaceutical Industries Company Summary